| Literature DB >> 32455618 |
Francisco Álvarez-Salvago1,2, Ana Lara-Ramos3, Irene Cantarero-Villanueva1,2,4, Maryna Mazheika5, Antonio Mundo-López6, Noelia Galiano-Castillo1,2,4, Carolina Fernández-Lao1,2,4, Manuel Arroyo-Morales1,2,4, Olga Ocón-Hernández4,7, Francisco Artacho-Cordón1,4,8,9.
Abstract
AIM: To explore endometriosis-related fatigue (ERF), health-related fitness, sleep quality, and health-related quality of life (HRQoL) in women with endometriosis in comparison with matched controls.Entities:
Keywords: chronic fatigue; endometriosis; health-related fitness; health-related quality of life; sleep quality
Year: 2020 PMID: 32455618 PMCID: PMC7277433 DOI: 10.3390/ijerph17103610
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Characteristics of the study population (N =50).
| Variables | Control Group | ENDO Group | |
|---|---|---|---|
|
| 34.5 ± 5.2 | 36.2 ± 3.7 | 0.150 |
|
| 0.185 | ||
|
| 21 (84.0) | 17 (68.0) | |
|
| 4 (16.0) | 8 (32.0) | |
|
| 0.333 | ||
|
| 8 (32.0) | 5 (20.0) | |
|
| 17 (68.0) | 20 (80.0) | |
|
|
| ||
|
| 23 (92.0) | 14 (56.0) | |
|
| 2 (8.0) | 11 (44.0) | |
|
| - | ||
|
| - | 19 (76.0) | |
|
| - | 6 (24.0) | |
|
| - | ||
|
| - | 7 (28.0%) | |
|
| - | 18 (72.0%) | |
|
| - | ||
|
| - | 7 (28.0%) | |
|
| - | 18 (72.0%) | |
|
| - | ||
|
| - | 6 (24.0) | |
|
| - | 11 (44.0) | |
|
| - | 8 (32.0) | |
|
| |||
|
| 164.0 ± 7.9 | 163.7 ± 5.5 | 0.796 |
|
| 62.36 ± 8.97 | 70.76 ± 15.87 | 0.175 |
|
| 22.98 ± 2.55 | 26.39 ± 6.05 | 0.054 |
|
| 24.05 ± 2.88 | 24.27 ± 3.39 | 0.920 |
|
| 28.23 ± 7.16 | 35.73 ± 8.93 |
|
* Mean ± standard deviation; MRI: magnetic resonance imaging; BMI: body mass index. ASRM: American Society for Reproductive Medicine. Bold numbers indicate significant differences between groups.
Figure 1Levels of endometriosis-related fatigue (ERF) in women with (ENDO group) and without endometriosis (control group). PFS: Piper Fatigue Scale. p-values were calculated through the Mann–Whitney U. *p - value < 0.050.
Health-related fitness in women with and without endometriosis.
| Outcome | Control Group ( | ENDO Group ( | |
|---|---|---|---|
|
| |||
|
| 63.20 ± 11.40 | 52.20 ± 14.70 |
|
| (58.26–68.12) | (46.17–58.28) | ||
|
| 26.50 ± 4.00 | 26.10 ± 4.70 | 0.712 |
| (24.53–27.46) | (24.18–28.07) | ||
|
| 25.20 ± 3.90 | 24.10 ± 5.00 | 0.295 |
| (23.35–26.01) | (22.04–26.18) | ||
|
| |||
|
| 15.00 ± 1.09 | 14.10 ± 1.06 |
|
| (14.48–15.46) | (13.70–14.58) | ||
|
| |||
|
| 0.02 ± 0.10 | 0.18 ± 0.32 |
|
| (−0,02–0.07) | (0.05–0.31) | ||
|
| |||
|
| 651.20 ± 54.30 | 561.20 ± 57.90 |
|
| (624.42–672.71) | (537.35–585.13) |
Values are expressed as mean ± standard deviation (95% confidence intervals for the mean). Bold numbers indicate significant differences between groups.
Perceived physical fitness, sleep quality, and quality of life in women with and without endometriosis.
| Outcome | Control Group | ENDO Group | |
|---|---|---|---|
|
| |||
|
| 3.60 ± 0.65 | 2.74 ± 0.81 |
|
| (3.31–3.86) | (2.39–3.09) | ||
|
| 3.25 ± 0.79 | 2.57 ± 0.90 |
|
| (2.91–3.59) | (2.18–2.95) | ||
|
| 3.63 ± 0.71 | 3.09 ± 0.85 |
|
| (3.32–3.93) | (2.72–3.45) | ||
|
| 3.71 ± 0.75 | 2.96 ± 0.56 |
|
| (3.39–4.03) | (2.71–3.20) | ||
|
| 3.38 ± 0.77 | 3.13 ± 1.06 | 0.408 |
| (3.05–3.70) | (2.67–3.59) | ||
|
| |||
|
| 6.00 ± 3.19 | 8.32 ± 3.72 |
|
| (4.68–7.32) | (6.79–9.85) | ||
|
| |||
|
| 55.09 ± 5.04 | 37.99 ± 13.08 |
|
| (53.01–57.17) | (31.68–44.29) | ||
|
| 49.56 ± 10.54 | 46.36 ± 11.66 | 0.271 |
| (45.21–53.91) | (40.74–51.99) |
Values are expressed as mean ± standard deviation (95% confidence intervals for the mean). HRQoL: health-related quality of life. Bold numbers indicate significant differences between groups